0byt3m1n1
Path:
/
home
/
artemisi
/
mail
/
.Trash
/
cur
/
[
Home
]
File: 1628698427.M340400P22415.cp05.machighway.com,S=3707,W=3785:2,S
Return-Path: <> Delivered-To: artemisi@cp05.machighway.com Received: from cp05.machighway.com by cp05.machighway.com with LMTP id qGB5GV5wTV2XJgAAO6ibsw (envelope-from <>) for <artemisi@cp05.machighway.com>; Fri, 09 Aug 2019 09:08:46 -0400 Return-path: <> Envelope-to: artemisi@cp05.machighway.com Delivery-date: Fri, 09 Aug 2019 09:08:46 -0400 Received: from mailnull by cp05.machighway.com with local (Exim 4.92) id 1hw4dS-0003OO-6U for artemisi@cp05.machighway.com; Fri, 09 Aug 2019 09:08:46 -0400 X-Failed-Recipients: kirtanadmin@shubalananda.com Auto-Submitted: auto-replied From: Mail Delivery System <Mailer-Daemon@cp05.machighway.com> To: artemisi@cp05.machighway.com Content-Type: multipart/report; report-type=delivery-status; boundary=1565356126-eximdsn-752459693 MIME-Version: 1.0 Subject: Mail delivery failed: returning message to sender Message-Id: <E1hw4dS-0003OO-6U@cp05.machighway.com> Date: Fri, 09 Aug 2019 09:08:46 -0400 --1565356126-eximdsn-752459693 Content-type: text/plain; charset=us-ascii This message was created automatically by mail delivery software. A message that you sent could not be delivered to one or more of its recipients. This is a permanent error. The following address(es) failed: kirtanadmin@shubalananda.com No Such User Here --1565356126-eximdsn-752459693 Content-type: message/delivery-status Reporting-MTA: dns; cp05.machighway.com Action: failed Final-Recipient: rfc822;kirtanadmin@shubalananda.com Status: 5.0.0 --1565356126-eximdsn-752459693 Content-type: message/rfc822 Return-path: <artemisi@cp05.machighway.com> Received: from artemisi by cp05.machighway.com with local (Exim 4.92) (envelope-from <artemisi@cp05.machighway.com>) id 1hw4dR-0003OG-Ka for kirtanadmin@shubalananda.com; Fri, 09 Aug 2019 09:08:46 -0400 To: kirtanadmin@shubalananda.com Subject: [Shubalananda Kirtan] Please moderate: "Welcome to the new Shubalananda Kirtan website!" X-PHP-Script: shubalananda.com/wp-comments-post.php for 5.188.211.13 Date: Fri, 9 Aug 2019 13:08:45 +0000 From: WordPress <wordpress@shubalananda.com> Message-ID: <e66ae718bb5c65f6a64a6f794afa64a9@shubalananda.com> X-Mailer: PHPMailer 5.2.22 (https://github.com/PHPMailer/PHPMailer) MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 A new comment on the post "Welcome to the new Shubalananda Kirtan website!" is waiting for your approval http://shubalananda.com/2017/09/25/welcome-to-the-new-shubalananda-kirtan-website/ Author: Norman (IP address: 5.188.211.13, 5.188.211.13) Email: randolphf21@lycos.com URL: http://j-designs.net/atropine-eye-drops-d4ab.pdf Comment: I've just started at <a href="https://anhhaimobile.com/vitalix-plus-indonesia-472a.pdf" rel="nofollow">vitalix pills reviews</a> China accounts for less than 4pc of global sales, but GSK has invested heavily in the country, where it employs 7,000 people from basic research through to sales and marketing. The Chinese pharmaceuticals market is growing rapidly, expanding 20pc this year alone, according to research by consultancy McKinsey. In the same report, a third of the 50 pharmaceutical executives surveyed by the consultancy said they expected China to account for more than 10pc of global sales by 2018. Approve it: http://shubalananda.com/wp-admin/comment.php?action=approve&c=13382#wpbody-content Trash it: http://shubalananda.com/wp-admin/comment.php?action=trash&c=13382#wpbody-content Spam it: http://shubalananda.com/wp-admin/comment.php?action=spam&c=13382#wpbody-content Currently 12,371 comments are waiting for approval. Please visit the moderation panel: http://shubalananda.com/wp-admin/edit-comments.php?comment_status=moderated#wpbody-content --1565356126-eximdsn-752459693--